Orin
MSCINYSE·Financial - Data & Stock Exchanges

MSCI Inc.

Market cap $43.7BP/E 32.0× trailingGross margin 82.9%Reports Wed 27 Jan 2027, before the open
$601.75
−15.92 (−2.58%)Tue 27 Oct close 16:00 ET
52-wk $501.08 – $644.77
Orin's take
7out of 10 — how sure Orin is of this read

Orin's own judgment of how firmly the evidence points one way — not the chance the price goes up.

Refreshed 20 Oct, the 9th take on MSCI. A new filing or a print queues the next refresh.

MSCI's revenue growth is accelerating — quarterly YoY growth stepped up from 9.5% in Q3 2025 to 14.1% in Q1 2026 and 12.2% in Q2 2026 — while FY2025 margins remain best-in-class at 82.4% gross and 49.4% FCF, and the company just beat Q3 2026 EPS estimates with $5.11 actual versus $5.03 estimated.

The stock trades at a 19.7% P/E premium to the peer median of 26.0x but sits near five-year low multiples following a roughly 10% sell-off, and technicals are firming with price above the 50-day MA of $558.68 and a bullish MACD histogram of 2.31. The main caveat is balance-sheet leverage — total debt surged to $6.34B against negative equity of -$2.65B — but $1.55B in FY2025 free cash flow provides ample coverage, making the risk/reward attractive at current levels.

What could go wrong

  • Leverage and negative equity. Total debt rose to $6.34B at FY2025-end from $4.66B in FY2024, against negative stockholders' equity of -$2.65B, increasing financial fragility if rates stay elevated or growth disappoints.
  • Valuation premium to peers. MSCI trades at 31.2x P/E versus a peer median of 26.0x and 12.4x P/S versus 7.8x, leaving limited room for multiple compression if growth decelerates.
  • Expense guidance pressure. A recent sell-off was tied to raised expense guidance; if incentive compensation continues to outpace revenue growth, operating margin could compress from the 54.7% FY2025 level.
  • Index reclassification backlash. MSCI's proposal to reclassify Indonesia to Standalone Market status and its freeze on Turkey indexes could trigger regulatory or client pushback in emerging markets, potentially affecting index licensing revenue.

What would change my mind

Q4 2026 revenue growth sustains above 10%. Q4 2026 quarterly revenue YoY growth prints at or above 10%, confirming the acceleration trend from Q1 and Q2 2026.bullish
Debt reduction or deleveraging plan. Management announces meaningful debt paydown or a deleveraging target, reducing the $6.34B total debt burden.bullish
Operating margin compression below 52%. Quarterly operating margin falls below 52%, signaling that expense growth is outpacing revenue and eroding the FY2025 54.7% margin profile.bearish
Stock breaks below 50-day MA on volume. Price closes below $558.68 (50-day MA) on above-average volume, invalidating the improving technical setup.bearish

Where this comes from: quarterly results · fundamentals · earnings vs estimates · peer comparison. Orin's read on MSCI; not advice.

How has the share price moved?

27 Oct 2025 – 27 Oct 2026

Up 10.0% over twelve months, from $546.86 on 27 Oct 2025 to $601.75 at the Tue 27 Oct 2026 close. Its highest close in that time was $643.83 on 1 Jun 2026; the last close is 6.5% below it.

Jan 2026AprJulOct
    • Green line: the closing price each trading day.
    • Grey line: the average closing price over the last 50 trading days.
    • Dashed amber line: the same over the last 200 trading days — a slower, smoother line.
    • Bars along the bottom: shares traded each day — green when it closed higher than the day before, rose when lower (the most, 2.6M, on 26 Jun 2026).
    • Flags: the company's filings, on the day they were made (a 10-Q is the quarterly report and a 10-K the annual report; an 8-K reports a major event).

    Largest holders · 13F Q2 2026

    Money flow
    FilerPositionOf fund
    BlackRock$3.1B0.0%
    Vanguard Capital Management$2.6B0.1%
    Vanguard Portfolio Management$2.3B0.1%
    BAMCO$1.8B2.7%
    State Street$1.8B0.1%
    Morgan Stanley$1.2B0.1%
    Geode Capital Management$1.1B0.1%
    Viking Global Investors$650.0M1.9%
    Norges Bank$481.5M0.0%
    Invesco$452.4M0.0%

    97 of the 815 filers we track · quarter ended Q2 2026 · positions, not flows

    Insiders, last 24 months: 118 Form 4 filings; open-market trades net $5.3M. Of the 50 on hand, 16 were open-market purchases and 7 sales — the rest are grants, option exercises and tax withholding.

    Ask Orin about MSCI

    its filings · its transcripts · its numbers

    Orin answers questions about MSCI from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

    Start 3 free days →

    How is it priced, against its own past and its sector?

    Tue 27 Oct close

    Priced at 32.0× its last 12 months of profit (Tue 27 Oct close) — lower than in all 5 of its last 5 fiscal years (middle 42.6×); the typical Financial Services company on the NYSE is at 17.6×.

    MeasureNowIts usualSector
    P/E32.0×below usual42.6×17.6×
    P/S12.7×below usual16.7×—
    EV/EBITDA23.8×below usual29.5×—
    P/Bbelow zero——
    • P/B: below zero — it owes more than it owns on its books.
    • "Its usual" is the middle of its own last 5 fiscal years.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    P/S: the company's total market value divided by one year of revenue. Used when there is no profit to measure.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    P/B: the share price divided by the book value per share — what the company owns minus what it owes, as its accounts record it. When book value is tiny, P/B swings wildly and says little.

    What do the analysts who cover it publish?

    9 firms rated it in the last 18 months · 27 Oct

    The analysts' average 12-month price target is $688 (from $615 to $735) — 14% above the Tue 27 Oct close price. That is their published opinion, not Orin's.

    Average price target

    $688

    $615 – $735 · +14% against the last close

    Their ratings
    • 9 buy or overweight
    • 0 hold
    • 0 underweight or sell

    Price target: the share price an analyst publishes for about 12 months ahead. It is the opinion of the firm that wrote it; the average is across the firms that cover the company.

    Overweight / underweight: analysts' rating words: overweight means the firm expects the stock to do better than the others it covers, underweight worse. Their words, not Orin's.

    How is it priced next to the companies it is compared to?

    middle P/E 27.3× · 3 of 3 with a profit

    Priced at 32.0× its last 12 months of profit; the middle P/E of the 3 companies it is compared to that made a profit is 27.3×.

    CompanyMarket valueP/EEV/EBITDAGross marginNet marginROE
    MSCIMSCI Inc.$44B32.0×23.8×82.9%40.3%n/m
    FDSFactSet Research Systems Inc.$11B21.2×13.5×50.6%21.5%26%
    MCOMoody's Corporation$82B28.8×22.8×73.1%35.3%86%
    SPGIS&P Global Inc.$132B27.3×17.4×70.9%30.5%17%
    • MSCI: return on equity is not meaningful (n/m) — book value is below zero.
    • The list of companies is the data vendor's choice, so it can include a company a person would not have picked.

    Market value: the share price times the number of shares — what the whole company is priced at.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    Gross margin: the share of each $1 of sales left after the direct cost of making what was sold.

    Net margin: the share of each $1 of sales kept as profit after every cost. Below zero, the company lost money.

    ROE: return on equity: one year of profit as a share of the shareholders' money in the business (its book value).

    Is it priced high or low compared with its own past?

    Tue 27 Oct

    Priced at 32.0× its last 12 months of profit (Tue 27 Oct close). It has no full fiscal year on file since its history starts, so there is nothing of its own to compare with.

    • Now32.0×

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    Fiscal year (FY): the company's own 12-month accounting year, which need not match the calendar year.

    How has its sector been priced?

    Now–Now · Tue 27 Oct

    Financial Services companies on the NYSE were priced at a typical 17.6× their yearly profit (Tue 27 Oct close).

    • Now17.6×
    • Each year is the middle of that calendar year's daily sector P/E; "Now" is the Tue 27 Oct close figure, the same one in the table above.

    Sector P/E: the middle P/E of the companies in the same sector on the same stock exchange, as the data vendor works it out each day.

    What does a cash-flow model say a share is worth?

    computed 27 Oct at $606.79

    A standard cash-flow model puts it at $293 a share — 52% below the $606.79 price it was computed against (27 Oct).

    ModelValue a shareAgainst the price then
    Standard$29352% below $606.79
    Levered$31249% below $606.79

    Discounted cash flow: a model's estimate of what the company is worth today, from the cash it is forecast to make in future years. Small changes in the forecast move it a lot, and it says little about a company that loses money.

    Standard / levered: two versions of the cash-flow model: the standard one counts the cash before the company pays its lenders, the levered one after.